Hizentra® – Human Normal Immunoglobulin (SCIG)

SKU: deb10517653c-7 Category:
Brand Name


Generic Name

Human Normal Immunoglobulin (SCIG)


A. Replacement therapy in adults and children in primary immunodeficiency syndromes such as:
• congenital agammaglobulinaemia and hypogammaglobulinaemia
• common variable immunodeficiency
• severe combined immunodeficiency and Wiskott-Aldrich syndrome
• IgG subclass deficiencies with recurrent infections

B. Replacement therapy in secondary immunodeficiencies (SID) in patients with severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l.
*PSAF=failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal polysaccharide and polypeptide antigen vaccines.

C. Immunomodulatory therapy:
• Hizentra is indicated for the treatment of patients with chronic inflammatory
demyelinating polyneuropathy (CIDP) as maintenance therapy to prevent relapse of
neuromuscular disability and impairment.

Dosage Forms

Solution for subcutaneous injection, Vial, 200 mg/1mL, 5mL
Solution for subcutaneous injection, Vial, 200 mg/1mL, 10mL
Solution for subcutaneous injection, Vial, 200 mg/1mL, 20mL

Rout of Administration

Subcutaneous injection


• Do not store above 25 °C.
• Do not freeze.
• Keep the vial in the outer carton in order to protect from light.


CSL Behring AG

Country of Origin